Active ingredientTriazolamCat. No. P-T191-001CAS 28911-01-5Family · Pharmaceutical analytical standards
Triazolam
A very short-acting benzodiazepine with a triazole ring, patented in 1970 and first marketed in the United States in 1982: it is used for the short-term treatment of acute insomnia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is almost identical to alprazolam: the two molecules differ by a single chlorine atom, yet one is used for sleep and the other for anxiety.
Go to the active ingredient →Active ingredientTriazolamCat. No. P-T191-001CAS 28911-01-5
Isotopically labelledTriazolam-d3Cat. No. P-T191-002CAS 112393-65-4
ImpurityTriazolam Impurity 1Cat. No. P-T191-003CAS 54567-12-3
Impurity4-Hydroxy TriazolamCat. No. P-T191-004CAS 65686-11-5
Impurityalpha-Hydroxy TriazolamCat. No. P-T191-005CAS 37115-45-0
ImpurityTriazolam Impurity 2Cat. No. P-T191-006CAS 64445-00-7
ImpurityTriazolam Impurity 3Cat. No. P-T191-007CAS 75450-52-1
ImpurityTriazolam Impurity 4Cat. No. P-T191-008CAS 54196-62-2No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceTriazolam CRSEDQM code T1975000Family TriazolamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.